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Malignant Schwannoma of Anterior Abdominal 
Wall: Report of a Case
Zhamak Khorgamia, Shirzad Nasiria, b, Freshteh Rezakhanlua, Nassim Sodagaria
Abstract
Malignant  schwannoma  of  the  anterior  abdominal  wall 
nerves is extremely rare. Malignant peripheral nerve sheath tumors 
(MPNST) represent approximately 10% of all soft tissue sarco-
mas and it is found in 4% of patients with neurofibromatosis 1. 
We present a case of malignant schwannoma in a 28-year-old fe-
male patient with neurofibromatosis 1. She presented with a pain-
ful mass in the right upper quadrant of her abdomen. The tumor 
location was in the abdominal wall in explorative laparatomy and 
malignant schwannoma was diagnosed in pathologic assessment. 
The tumor recurred in 3 months and computed tomography showed 
two masses in the right side of abdominopelvic cavity. Thereafter, 
second complete surgical resection was performed and pathologic 
finding was the same. In spite of administering chemotherapy after 
second surgery, the tumor recurred and magnetic resonance imag-
ing finding showed a huge heterogeneously enhancing mass with 
adhesion to the inner side of the abdominal wall. The patient died 
because of acute respiratory failure due to multiple bilateral pulmo-
nary metastases. Tumor location and rapid recurrence was unique 
in our patient.
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Introduction
 
  A  28  years  old  woman  with  recurrent  malignant 
schwannoma  originating  from  anterior  abdominal  wall 
nervesis reported in our article. Malignant peripheral nerve 
sheath  tumor  also  known  as  malignant  schwannoma,  are 
highly malignant sarcomas that tend to arise in the head and 
neck region or on the exterimities, and only very  rarely in 
anterior abdomional wall. Almost 50% of cases are associ-
ated  with  neurofibromatosis. Although  various  radiologic 
imaging methods are helpful for identifying some features 
of the mass, definitive diagnosis requires histological exami-
nation and immunohistochemical staining. After treatment, 
the tumor recurs in 25% of patients. Five-year survival rates 
as high as 80% have been reported. Total excision and lack 
of invasion of surrounding tissue and vessels and absence 
of   neurofibromatosis are features associated with better out-
come.
 
Case presentation
   A 28 years old female was admitted for management of 
increasing abdominal distention and sustained pain in right 
upper quadrant of abdomen for two months. Her medical 
history included type 1 neurofibromatosis (NF1), also known 
as von Recklinghausen disease. She had not history of sur-
gery or radiotherapy. On physical examination, there were 
multiple cafe-au-lait spots scattered over the patient’s entire 
body and axillary freckling, but no cutaneous neurofibromas 
was present (Fig. 1). Lisch nodules were not detected in the 
iris by a slit lamp. A large firm fixed mass was palpated in the 
right portion of the abdomen. 
  The sonographic and computed tomography findings 
showed a heterogenic solid mass in right upper quadrant 
(RUQ) of abdomen that extended down to the right lower 
quadrant (RLQ) of abdomen (Fig. 2). Laboratory data was 
in normal range. Thereafter the patient underwent a surgi-
cal resection. During the operation, an encapsulated, white 
grayish, bulky, fish fleshy mass attached to the abdominal 
wall measuring 16 × 13 × 6 cm was detected in the right side 
of abdomen. There was no local invasion, and the tumor was 
resected en block. The cut surface showed cystic and sol-
id components with hemorrhagic foci. Pathologic findings 
showed atypical spindle cells with mild pleomorphism and 
high mitotic activity that suggest malignant peripheral nerve 
sheet tumor (malignant schwannoma). Patient didn’t follow 
the recommendations for postoperative adjuvant therapy. Af-
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ter three months, she came with local recurrence of tumor.
  Radiologic findings showed two masses in the right 
anterior pararenal space extending down to the lower abdo-
men. Thereafter the patient underwent second surgical resec-
tion. During the second operation, one white grayish well 
limited fish fleshy tumor measuring 6.1 × 5.5 × 4.7 having 
whitish out surface with gelatinous foci and the other  mass 
measuring 2.1 × 1.9 × 1.8 cm, were detected in the abdomen 
and resected. Section showed a high grade spindle cell hy-
percellular sarcoma composed of rather monotonous spindle 
cells having atypical hyperchromatic nuclei with foci of peri-
vascular palisading. Histological examination of the resected 
specimen revealed the tumor to be malignant schwannoma. 
The patient received chemotherapy (cyclophosphamide) for 
2 months but there was tumor recurrence in less than two 
months. Magnetic resonance imaging showed the recurrent 
tumor as a huge heterogeneously enhancing mass with some 
necrotic foci which has filled the abdomen and pelvic cavi-
ties. The mass was located in right side of the abdomen with 
midline extension (Fig. 3).
Discussion
  
 The occurrence of intraabdominal and retroperitoneal 
schwannomas is extremely rare. Intraabdominal schwanno-
mas occur most frequently in the alimentary tract [1]. Gas-
trointestinal involvement occurs in about 10% to 25% of 
patients with NF1 and includes solitary or multiple neuro-
fibromas, leiomyomas, and rarely, plexiform neurofibromas 
[2].
  Neurofibromas are tumors derived from Schwann cells, 
fibroblasts, and supporting cells known as perineural cells. 
Typically, they are benign and manifest as multiple tumors. 
NF1 is an autosomal dominant genetic disorder with a preva-
lence of approximately 1 in 4,000 births and no racial pre-
dilection. NF1 is characterized by multiple neurofibromas 
along the peripheral nerves, optic nerve gliomas, sphenoid 
wing dysplasia, pigmented lisch nodules, and hyperpigment-
ed macular skin lesions known as cafe-au-lait spots. It is as-
sociated with a gene on chromosome 17. The formation of 
dermal neurofibromas is a hallmark of NF1 with a character-
istic distribution on the trunk and sparing of the extremities. 
With time, neurofibromas may undergo malignant degenera-
tion [3].
 At gross examination, neurofibromas appear as firm, 
gray-white  masses.  At  histologic  analysis,  neurofibromas 
contain Schwann cells and nerve fibers that grow in a dis-
organized fashion and appear as interlacing bundles of elon-
gated cells with intracellular collagen strands.  
  There are three types of neurofibromas: localized, dif-
fuse, and plexiform. The vast majorities of these lesions are 
localized and have no association with NF1, although any 
Figure 1. Multiple cafe-au-lait spots scattered over the patient’s 
entire body.
Figure 2. Abdominopelvic Computed Tumography shows a large mass in the right side of abdominal cavity.
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of these lesions may occur in NF1 [4]. Localized neurofi-
bromas are well-delineated, firm lesions with a white and 
shiny surface and may appear in the dermis or subcutaneous 
tissues. Plexiform neurofibromas are thick, fusiform, rope-
like expansions of nerve roots and peripheral nerve fibers 
with a mucoid or translucent cut surface. They are generally 
unencapsulated tumors that blend indistinctly with adjacent 
connective tissue or peripheral nerves and are diagnostic of 
NF1. Their gross appearance is often described as a “bag of 
worms”. Rapid enlargement of an existing neurofibroma may 
be a sign of malignant transformation until proved otherwise 
[3]. A malignant peripheral nerve sheath tumor (MPNST) is 
now the preferred name for the spindle cell malignancy of 
peripheral nerve schwann cells. Malignant schwannoma are 
the malignant variants of schwannomas and neurofibromas 
[5]. MPNSTs most commonly occur in the deep soft tissues, 
usually close to a nerve trunk. The most common sites are the 
sciatic nerves, brachial plexus, and sacral plexus. The past 
literature  referred  to  MPNST  as  malignant  schwannoma, 
neurogenic sarcoma, and neurofibrosarcoma. MPNST is the 
current term used by the World Health Organization for this 
highly aggressive tumor. MPNSTs may arise from plexiform 
neurofibromas, de novo or secondary to radiation therapy. 
At histologic analysis, the presence of mitotic figures distin-
guishes MPNST from otherwise typical neurofibromas [2]. 
It represents approximately 10% of all soft tissue sarcomas 
and its diagnosis has been called one of the most difficult and 
elusive diagnoses in soft tissue diseases. It is found in at least 
4% of patients with neurofibromatosis 1, where its develop-
ments are to be a multi-step, multi-gene process. 
  Conversely, up to half of all cases of MPNST are diag-
nosed in persons with neurofibromatosis 1. About one in ten 
cases are associated with irradiation [6]. Tumor is usually 
found in the lower extremities, but one-ninth of all lesions 
occur in the head and neck region, usually associated with 
the large cranial nerves. MPNSTs occur rarely in the retro-
peritoneum [5]. Lesions related to neurofibromatosis typical-
ly occur a decade or more earlier than those in non-syndrome 
patients. MPNST occurs usually in 20-50 years of age, but 
children and elderly may also be affected. Clinically, pain 
is a classic presenting symptom in MPNST. Other findings 
include masses larger than 2–6 cm with irregular borders and 
a history of rapid growth. Often, MPNST produces neuro-
logic deficits in the distribution of the involved nerves due 
to impingement or mass effect. At computed tomography, 
the attenuation of neurogenic tumors depends on their his-
tologic characteristics. Neurofibromas typically have low at-
tenuation related to the fat content of myelin from Schwann 
cells, the high water content of myxoid tissue, entrapment 
of fat and cystic areas of hemorrhage and necrosis. Central 
enhancement or a target appearance may be seen due to the 
less cellular and vascular myxoid tissue located in the pe-
riphery and more vascular fibrous tissue seen centrally. The 
characteristic dumbbell lesion, a partly intradural and partly 
extradural tumor, represents a neurofibroma that expands the 
intervertebral foramina and may be best appreciated with 
cross-sectional imaging. Ultrasound of a neurofibroma re-
veals a hypoechoic, well-defined mass [3]. Although vari-
ous radiologic imaging methods are helpful for identifying 
some features of neurofibroma, definitive diagnosis requires 
histologic examination and immunohistochemical staining 
[5]. Radiologically, MPNSTs and neurofibromas may appear 
indistinguishable;  however,  certain  modalities  are  provid-
ing insight for differentiation. Gallium-67 citrate imaging 
has shown that MPNSTs have greater uptake compared with 
benign lesions. At magnetic resonance imaging, the differ-
ent signal intensity characteristics of lesions with a higher 
degree of anaplasia are proving useful as well. Other factors 
such as a more rapid and infiltrative growth pattern are par-
ticularly helpful in differentiating these lesions [7]. 
  Surgical resection is the first line of therapy, ideally 
with total removal of the tumor. Gross inspection of MPNSTs 
reveals a fusiform, fleshy, tan-white mass with areas of de-
generation and secondary hemorrhage. The nerve proximal 
and distal to the tumor may be thickened due to spread of the 
tumor along the epineurium and perineurium. At histologic 
analysis,  MPNSTs  are  unencapsulated  infiltrating  tumors 
composed of spindle cells arranged in a whorling pattern 
with irregular nuclei, cyst formation, and nuclear palisad-
ing. Mitotic figures are readily visible, with more than one 
per high-power field, and 50%–90% of cases are immuno-
reactive with S100 protein staining. Owing to a high risk of 
recurrence with incomplete resection, postoperative irradia-
tion and chemotherapy are necessary; however, they are of-
ten used as adjuvant therapy even if the tumor is completely 
resected. Even with aggressive therapy, local recurrence of 
tumor is seen in 50% of patients. Hematogenous metastatic 
spread occurs most commonly to the lungs. The reported 
Figure 3. Magnetic Resonance Imaging shows huge heteroge-
neously enhancing mass with some necrotic foci which has filled 
the abdominal and pelvic cavities.
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5-year survival rate for patients with MPNST without NF1 
is as high as 50%. It drops to as low as 10% for MPNST pa-
tients with NF1 [2]. The five-year survival rate of malignant 
schwannoma is low, primarily due to poor response of the 
tumors to available treatments and metastasis to the lungs 
and other organs. Patients that usually have the best outlook 
are those that are young and have relatively small tumors 
able to be completely removed via surgical means. Total ex-
cision, lack of invasion of surrounding tissues and vessels, 
and absence of neurofibromatosis, are features associated 
with better outcome [5]. Genetic counseling of family mem-
bers suspected to have this disease should be performed [3].
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